Keyphrases
2-year Follow-up
50%
Budesonide
100%
Budesonide Foam
100%
Clinical Remission
100%
Confidence Interval
75%
Disease Duration
50%
Endoscopic Remission
100%
Hazard Ratio
25%
Maintenance of Remission
25%
Mayo Endoscopic Subscore
25%
Mucosal Healing
75%
Phase III Clinical Trial
25%
Proctosigmoiditis
25%
Rectal Foam
100%
Relapse Predictors
25%
Relapse-free Survival
25%
Remission
100%
Survival Time
25%
Topical Preparation
25%
Ulcerative Colitis
100%
Ulcerative Colitis Patient
100%
Pharmacology, Toxicology and Pharmaceutical Science
Budesonide
100%
Clinical Trial
11%
Disease Duration
22%
Recurrence Free Survival
11%
Remission
100%
Survival Time
11%
Ulcerative Colitis
100%
Medicine and Dentistry
Budesonide
100%
Clinical Trial
16%
Disease Duration
33%
Hazard Ratio
16%
Patient with Ulcerative Colitis
100%
Recurrence Free Survival
16%
Survival Time
16%
Ulcerative Colitis
50%